About Us

BLASTID, Inc. is developing diagnostic solutions to solve the most pressing global healthcare threats. Backed by the largest government grant in Harvard University’s history (read more about the award here), the Paulsson lab has created a groundbreaking set of technologies that can rapidly identify and assay individual cells, including drug-resistant pathogens. These breakthroughs form the cornerstone of BLASTID’s approach to stemming the growing antimicrobial resistance crisis. With its unique platform and innovative market position, BLASTID is poised to become the worldwide leader in next-generation diagnostic testing, setting a new standard for speed, accuracy, and patient impact.